Cargando…

Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice today. For those who present with it, one of the most major risks associated with the condition is stroke. AF is associated with a fivefold increased risk of stroke and thromboembolism. Oral anticoagula...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraj, Ilir, Gonzalez, Mario D., Naccarelli, Gerald V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252752/
https://www.ncbi.nlm.nih.gov/pubmed/32477818
http://dx.doi.org/10.19102/icrm.2018.090801
_version_ 1783539211601707008
author Maraj, Ilir
Gonzalez, Mario D.
Naccarelli, Gerald V.
author_facet Maraj, Ilir
Gonzalez, Mario D.
Naccarelli, Gerald V.
author_sort Maraj, Ilir
collection PubMed
description Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice today. For those who present with it, one of the most major risks associated with the condition is stroke. AF is associated with a fivefold increased risk of stroke and thromboembolism. Oral anticoagulation has been the cornerstone of stroke prevention in patients with AF. In some individuals who exhibit a higher risk of bleeding, other alternatives for stroke prevention have been sought, including the use of left atrial appendage occlusion devices and surgical exclusion of the left atrial appendage. Catheter ablation is an important treatment strategy in those patients for whom a rhythm control strategy has been selected. This article reviews some of the available anticoagulant drug options and their use prior to, during, and after catheter ablation.
format Online
Article
Text
id pubmed-7252752
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MediaSphere Medical
record_format MEDLINE/PubMed
spelling pubmed-72527522020-05-28 Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation Maraj, Ilir Gonzalez, Mario D. Naccarelli, Gerald V. J Innov Card Rhythm Manag Research Review Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice today. For those who present with it, one of the most major risks associated with the condition is stroke. AF is associated with a fivefold increased risk of stroke and thromboembolism. Oral anticoagulation has been the cornerstone of stroke prevention in patients with AF. In some individuals who exhibit a higher risk of bleeding, other alternatives for stroke prevention have been sought, including the use of left atrial appendage occlusion devices and surgical exclusion of the left atrial appendage. Catheter ablation is an important treatment strategy in those patients for whom a rhythm control strategy has been selected. This article reviews some of the available anticoagulant drug options and their use prior to, during, and after catheter ablation. MediaSphere Medical 2018-08-15 /pmc/articles/PMC7252752/ /pubmed/32477818 http://dx.doi.org/10.19102/icrm.2018.090801 Text en Copyright: © 2018 Innovations in Cardiac Rhythm Management http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Review
Maraj, Ilir
Gonzalez, Mario D.
Naccarelli, Gerald V.
Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
title Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
title_full Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
title_fullStr Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
title_full_unstemmed Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
title_short Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
title_sort periprocedural use of oral anticoagulation therapy in patients undergoing atrial fibrillation ablation
topic Research Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252752/
https://www.ncbi.nlm.nih.gov/pubmed/32477818
http://dx.doi.org/10.19102/icrm.2018.090801
work_keys_str_mv AT marajilir periproceduraluseoforalanticoagulationtherapyinpatientsundergoingatrialfibrillationablation
AT gonzalezmariod periproceduraluseoforalanticoagulationtherapyinpatientsundergoingatrialfibrillationablation
AT naccarelligeraldv periproceduraluseoforalanticoagulationtherapyinpatientsundergoingatrialfibrillationablation